Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.450 EUR
−28.89 M EUR
28.57 M EUR
43.20 M
About GENFIT
Sector
CEO
Pascal Prigent
Headquarters
Loos
Website
Founded
1999
ISIN
FR0004163111
FIGI
BBG00GVJW583
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0QT6 is 3.965 EUR — it has decreased by −1.60% in the past 24 hours. Watch GENFIT EUR0.25 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange GENFIT EUR0.25 stocks are traded under the ticker 0QT6.
0QT6 stock has fallen by −1.60% compared to the previous week, the month change is a −20.44% fall, over the last year GENFIT EUR0.25 has showed a 32.53% increase.
We've gathered analysts' opinions on GENFIT EUR0.25 future price: according to them, 0QT6 price has a max estimate of 11.90 EUR and a min estimate of 7.00 EUR. Watch 0QT6 chart and read a more detailed GENFIT EUR0.25 stock forecast: see what analysts think of GENFIT EUR0.25 and suggest that you do with its stocks.
0QT6 reached its all-time high on Feb 20, 2015 with the price of 68.300 EUR, and its all-time low was 2.765 EUR and was reached on Dec 10, 2021. View more price dynamics on 0QT6 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0QT6 stock is 1.20% volatile and has beta coefficient of 2.16. Track GENFIT EUR0.25 stock price on the chart and check out the list of the most volatile stocks — is GENFIT EUR0.25 there?
Today GENFIT EUR0.25 has the market capitalization of 198.45 M, it has decreased by −4.85% over the last week.
Yes, you can track GENFIT EUR0.25 financials in yearly and quarterly reports right on TradingView.
GENFIT EUR0.25 is going to release the next earnings report on Apr 10, 2025. Keep track of upcoming events with our Earnings Calendar.
0QT6 earnings for the last half-year are 0.53 EUR per share, whereas the estimation was 0.31 EUR, resulting in a 70.97% surprise. The estimated earnings for the next half-year are 0.23 EUR per share. See more details about GENFIT EUR0.25 earnings.
GENFIT EUR0.25 revenue for the last half-year amounts to 61.20 M EUR, despite the estimated figure of 47.50 M EUR. In the next half-year revenue is expected to reach 28.13 M EUR.
0QT6 net income for the last half-year is 30.31 M EUR, while the previous report showed −8.04 M EUR of net income which accounts for 477.00% change. Track more GENFIT EUR0.25 financial stats to get the full picture.
No, 0QT6 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 27, 2024, the company has 159.00 employees. See our rating of the largest employees — is GENFIT EUR0.25 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENFIT EUR0.25 EBITDA is 17.71 M EUR, and current EBITDA margin is −122.29%. See more stats in GENFIT EUR0.25 financial statements.
Like other stocks, 0QT6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENFIT EUR0.25 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENFIT EUR0.25 technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENFIT EUR0.25 stock shows the sell signal. See more of GENFIT EUR0.25 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.